The ClpP activator ONC‐212 (TR‐31) inhibits BCL2 and B‐cell receptor signaling in CLL
暂无分享,去创建一个
E. Iwanowicz | R. Christopherson | O. G. Best | S. Mulligan | D. Karanewsky | Narjis Fatima | Kyle R Crassini | Yandong Shen | Henk Lang | Kyle Crassini